首页 > 最新文献

North American journal of medicine & science最新文献

英文 中文
Do Apparent Overlaps between Schizophrenia and Autistic Spectrum Disorders Reflect Superficial Similarities or Etiological Commonalities? 精神分裂症和自闭症谱系障碍之间的表面重叠反映的是表面相似性还是病因共性?
Pub Date : 2011-07-25 DOI: 10.7156/v4i3p124
William S Stone, Lisa Iguchi

STUDY BACKGROUND: Schizophrenia and autism are both neurodevelopmental disorders that were once considered to be the same disorder expressed in different developmental periods. Although they were separated diagnostically about 40 years ago, they share several clinical and possibly, etiological features. This paper reviews overlaps in four domains of function to consider the issue of whether these similarities are sporadic and likely to represent superficial similarities, or whether the disorders are more likely to share some features in common. METHODS: Representative areas of function were reviewed and compared for aspects of cognition (nonverbal reasoning, memory and language), social function (orienting/joint attention, eye contact and theory of mind), brain function (structural differences) and genetics. To facilitate comparisons with schizophrenia, a focus on high functioning autism/Asperger's disorder was utilized, particularly in the sections on cognition and social function. RESULTS: Significant similarities (and differences) characterized comparisons in each domain. CONCLUSIONS: Disturbed function in similar clinical (in cognition and social function), neurobiological (brain volumes) and genetic (e.g., involvement of the same genes or chromosomal locations) domains in autism and schizophrenia supports the hypothesis that while they are distinct disorders, they are not entirely unique. Additional studies of similarities and differences between them may thus shed light on common etiological mechanisms and hopefully, facilitate the development of novel treatment targets.

研究背景:精神分裂症和自闭症都是神经发育性疾病,曾被认为是在不同发育时期表现出来的同一种疾病。虽然大约 40 年前它们在诊断上被分开了,但它们有一些共同的临床特征,也可能有一些共同的病因特征。本文回顾了这两种疾病在四个功能领域的重叠之处,以探讨这些相似之处是偶发性的,可能只是表面上的相似,还是这两种疾病更有可能具有某些共同特征。 方法:对认知(非语言推理、记忆和语言)、社会功能(定向/联合注意、目光接触和心智理论)、大脑功能(结构差异)和遗传学等方面具有代表性的功能领域进行回顾和比较。为了便于与精神分裂症进行比较,研究重点放在了高功能自闭症/阿斯伯格综合症上,尤其是在认知和社会功能部分。 结果:每个领域的比较都有显著的相似性(和差异)。 结论:自闭症和精神分裂症在类似的临床(认知和社会功能)、神经生物学(脑容量)和遗传学(如相同基因或染色体位置的参与)领域的功能紊乱支持了这样一种假设,即虽然它们是不同的疾病,但并不完全是唯一的。因此,对它们之间的异同进行更多的研究可能会揭示共同的病因机制,并有望促进新型治疗目标的开发。
{"title":"Do Apparent Overlaps between Schizophrenia and Autistic Spectrum Disorders Reflect Superficial Similarities or Etiological Commonalities?","authors":"William S Stone, Lisa Iguchi","doi":"10.7156/v4i3p124","DOIUrl":"10.7156/v4i3p124","url":null,"abstract":"<p><p>STUDY BACKGROUND: Schizophrenia and autism are both neurodevelopmental disorders that were once considered to be the same disorder expressed in different developmental periods. Although they were separated diagnostically about 40 years ago, they share several clinical and possibly, etiological features. This paper reviews overlaps in four domains of function to consider the issue of whether these similarities are sporadic and likely to represent superficial similarities, or whether the disorders are more likely to share some features in common. METHODS: Representative areas of function were reviewed and compared for aspects of cognition (nonverbal reasoning, memory and language), social function (orienting/joint attention, eye contact and theory of mind), brain function (structural differences) and genetics. To facilitate comparisons with schizophrenia, a focus on high functioning autism/Asperger's disorder was utilized, particularly in the sections on cognition and social function. RESULTS: Significant similarities (and differences) characterized comparisons in each domain. CONCLUSIONS: Disturbed function in similar clinical (in cognition and social function), neurobiological (brain volumes) and genetic (e.g., involvement of the same genes or chromosomal locations) domains in autism and schizophrenia supports the hypothesis that while they are distinct disorders, they are not entirely unique. Additional studies of similarities and differences between them may thus shed light on common etiological mechanisms and hopefully, facilitate the development of novel treatment targets.</p>","PeriodicalId":19338,"journal":{"name":"North American journal of medicine & science","volume":"4 3","pages":"124-133"},"PeriodicalIF":0.0,"publicationDate":"2011-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342590/pdf/nihms371678.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30599020","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diffuse Large B-cell Lymphoma, Differential Diagnosis and Molecular Stratification 弥漫性大b细胞淋巴瘤的鉴别诊断和分子分层
Pub Date : 2011-04-30 DOI: 10.7156/V4I1P067
Youjun Hu, Kaiyan Yang, J. Krause
Diffuse large B-cell lymphoma (DLBCL) is a clinically aggressive lymphoma. The diagnosis of DLBCL is based on morphological and immunophenotypical evaluation of the biopsy specimens. The pathologic diagnosis of DLBCL, while often straight forward, may be challenging from time to time, so much so that the most recent WHO classification of hematolymphoid neoplasms created two provisional categories dealing with the cases in which separation of DLBCL from other lymphomas can not be made with certainty. On the other hand, DLBCL is also a biologically and clinically heterogeneous entity. Treatment outcome in many cases has not been optimal. Research studies have provided new insight into the DLBCL and suggestions for further stratification of the disease to achieve better treatment outcomes. This review will highlight key differentiating points of the many different categories of lymphomas and non-lymphoid malignancies that need to be considered in the differential diagnosis of DLBCL. The current status of prognostic marker studies of DLBCL as an effort to further stratify DLBCL is also reviewed.
弥漫性大b细胞淋巴瘤(DLBCL)是一种临床侵袭性淋巴瘤。DLBCL的诊断是基于活检标本的形态学和免疫表型评估。DLBCL的病理诊断虽然通常是直截了当的,但有时可能具有挑战性,以至于最近WHO对血淋巴肿瘤的分类创建了两个临时类别,以处理无法确定将DLBCL与其他淋巴瘤区分开来的病例。另一方面,DLBCL也是一个生物学和临床异质性实体。在许多情况下,治疗结果并不理想。研究为DLBCL提供了新的见解,并建议进一步分层疾病以获得更好的治疗效果。这篇综述将强调在DLBCL鉴别诊断中需要考虑的许多不同类型的淋巴瘤和非淋巴样恶性肿瘤的关键区别点。此外,本文还回顾了DLBCL预后标志物研究的现状,以期进一步对DLBCL进行分层。
{"title":"Diffuse Large B-cell Lymphoma, Differential Diagnosis and Molecular Stratification","authors":"Youjun Hu, Kaiyan Yang, J. Krause","doi":"10.7156/V4I1P067","DOIUrl":"https://doi.org/10.7156/V4I1P067","url":null,"abstract":"Diffuse large B-cell lymphoma (DLBCL) is a clinically aggressive lymphoma. The diagnosis of DLBCL is based on morphological and immunophenotypical evaluation of the biopsy specimens. The pathologic diagnosis of DLBCL, while often straight forward, may be challenging from time to time, so much so that the most recent WHO classification of hematolymphoid neoplasms created two provisional categories dealing with the cases in which separation of DLBCL from other lymphomas can not be made with certainty. On the other hand, DLBCL is also a biologically and clinically heterogeneous entity. Treatment outcome in many cases has not been optimal. Research studies have provided new insight into the DLBCL and suggestions for further stratification of the disease to achieve better treatment outcomes. This review will highlight key differentiating points of the many different categories of lymphomas and non-lymphoid malignancies that need to be considered in the differential diagnosis of DLBCL. The current status of prognostic marker studies of DLBCL as an effort to further stratify DLBCL is also reviewed.","PeriodicalId":19338,"journal":{"name":"North American journal of medicine & science","volume":"106 1","pages":"67"},"PeriodicalIF":0.0,"publicationDate":"2011-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79033791","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Tumor Cell Selective Cytotoxicity and Apoptosis Induction by an Herbal Preparation from Brucea javanica. 鸦胆子中药制剂对肿瘤细胞的选择性细胞毒性及诱导凋亡作用。
Pub Date : 2011-04-25 DOI: 10.7156/v4i2p062
Hua Gao, Julie Lamusta, Wei-Fang Zhang, Rebecca Salmonsen, Yingwang Liu, Edward O'Connell, James E Evans, Sumner Burstein, Jason J Chen

The plant Brucea javanica has shown impressive efficacy for treating various diseases including cancer. However, the mechanism by which B. javanica acts is poorly understood. We have established tissue culture assays to study the effects of B. javanica on cervical and several other cancer cells. Our results demonstrated that the aqueous extract from B. javanica is selectively toxic to cancer cells. Induction of apoptosis by B. javanica appears to be a possible mechanism by which it kills cancer cells. Interestingly, a significant increase of p53 protein level was observed in these apoptotic cells. Our studies indicated that both p53-dependent and p53-independent activities contributed to herb-induced cell death. These results imply that further studies with B. javanica may lead to the development of novel anti-cancer drugs.

鸦嘴苋在治疗包括癌症在内的各种疾病方面显示出令人印象深刻的功效。然而,爪哇芽孢杆菌的作用机制尚不清楚。我们建立了组织培养实验来研究爪哇芽孢杆菌对宫颈癌和其他几种癌细胞的影响。我们的研究结果表明,水提物的爪哇是有选择性的毒性癌细胞。芥蓝诱导细胞凋亡似乎是其杀死癌细胞的可能机制。有趣的是,在这些凋亡细胞中观察到p53蛋白水平显著升高。我们的研究表明,p53依赖性和p53非依赖性活性都有助于草药诱导的细胞死亡。这些结果表明,对爪哇芽孢杆菌的进一步研究可能会导致新型抗癌药物的开发。
{"title":"Tumor Cell Selective Cytotoxicity and Apoptosis Induction by an Herbal Preparation from Brucea javanica.","authors":"Hua Gao,&nbsp;Julie Lamusta,&nbsp;Wei-Fang Zhang,&nbsp;Rebecca Salmonsen,&nbsp;Yingwang Liu,&nbsp;Edward O'Connell,&nbsp;James E Evans,&nbsp;Sumner Burstein,&nbsp;Jason J Chen","doi":"10.7156/v4i2p062","DOIUrl":"https://doi.org/10.7156/v4i2p062","url":null,"abstract":"<p><p>The plant Brucea javanica has shown impressive efficacy for treating various diseases including cancer. However, the mechanism by which B. javanica acts is poorly understood. We have established tissue culture assays to study the effects of B. javanica on cervical and several other cancer cells. Our results demonstrated that the aqueous extract from B. javanica is selectively toxic to cancer cells. Induction of apoptosis by B. javanica appears to be a possible mechanism by which it kills cancer cells. Interestingly, a significant increase of p53 protein level was observed in these apoptotic cells. Our studies indicated that both p53-dependent and p53-independent activities contributed to herb-induced cell death. These results imply that further studies with B. javanica may lead to the development of novel anti-cancer drugs.</p>","PeriodicalId":19338,"journal":{"name":"North American journal of medicine & science","volume":"4 2","pages":"62-66"},"PeriodicalIF":0.0,"publicationDate":"2011-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108096/pdf/nihms295783.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29921606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 39
Regulatory T Cells and Cardiovascular Diseases 调节性T细胞与心血管疾病
Pub Date : 2011-04-14 DOI: 10.7156/V4I4P178
Harish Jevallee, T. Tang, Xiang Cheng
Recent researches have substantiated the active participation of chronic low-grade inflammation in cardiovascular disease where immune responses contribute to disease initiation and progression. Regulatory T cells (Tregs) are a unique lineage of T cells and have been proved to play a key role in controlling both the innate and adaptive immune responses under physiological and pathological conditions. Through suppression of immune system activation, Tregs are involved in tolerance to self antigens, thus maintaining immune homeostasis. Existence and function of Tregs were a matter of considerable debate over the last few decades, but owing to innovative molecular categorization of this specialized subpopulation of T cells, they have now been established as fundamental elements in the vertebrate immune system. In view of the prospective therapeutic avenues that Tregs may offer, we hereby review the current knowledge on the role of Tregs immunity in cardiovascular disease. [N A J Med Sci. 2011;4(4): 178-182 .]
最近的研究证实了慢性低度炎症在心血管疾病中的积极参与,其中免疫反应有助于疾病的发生和进展。调节性T细胞(Regulatory T cells, Tregs)是一种独特的T细胞谱系,已被证明在生理和病理条件下控制先天和适应性免疫反应中发挥关键作用。Tregs通过抑制免疫系统激活,参与对自身抗原的耐受,从而维持免疫稳态。treg的存在和功能在过去的几十年里一直是一个相当有争议的问题,但由于对这一特殊T细胞亚群的创新分子分类,它们现在已经被确定为脊椎动物免疫系统的基本元素。鉴于Tregs可能提供的前瞻性治疗途径,我们在此回顾目前关于Tregs免疫在心血管疾病中的作用的知识。[J] .中华医学杂志,2011;4(4):178-182。
{"title":"Regulatory T Cells and Cardiovascular Diseases","authors":"Harish Jevallee, T. Tang, Xiang Cheng","doi":"10.7156/V4I4P178","DOIUrl":"https://doi.org/10.7156/V4I4P178","url":null,"abstract":"Recent researches have substantiated the active participation of chronic low-grade inflammation in cardiovascular disease where immune responses contribute to disease initiation and progression. Regulatory T cells (Tregs) are a unique lineage of T cells and have been proved to play a key role in controlling both the innate and adaptive immune responses under physiological and pathological conditions. Through suppression of immune system activation, Tregs are involved in tolerance to self antigens, thus maintaining immune homeostasis. Existence and function of Tregs were a matter of considerable debate over the last few decades, but owing to innovative molecular categorization of this specialized subpopulation of T cells, they have now been established as fundamental elements in the vertebrate immune system. In view of the prospective therapeutic avenues that Tregs may offer, we hereby review the current knowledge on the role of Tregs immunity in cardiovascular disease. [N A J Med Sci. 2011;4(4): 178-182 .]","PeriodicalId":19338,"journal":{"name":"North American journal of medicine & science","volume":"68 7 1","pages":"178"},"PeriodicalIF":0.0,"publicationDate":"2011-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91020620","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Management of Initial HBV Therapy for an HBeAg-Negative Patient: A Case Discussion hbeag阴性患者初始HBV治疗的管理:一例讨论
Pub Date : 2011-01-31 DOI: 10.7156/V4I1P050
C. Pan, K. Hu
A case study of a 45-year-old Chinese woman with chronic hepatitis B (CHB) diagnosed in 1999 …...
1999年诊断为慢性乙型肝炎(CHB)的45岁中国女性病例研究......
{"title":"Management of Initial HBV Therapy for an HBeAg-Negative Patient: A Case Discussion","authors":"C. Pan, K. Hu","doi":"10.7156/V4I1P050","DOIUrl":"https://doi.org/10.7156/V4I1P050","url":null,"abstract":"A case study of a 45-year-old Chinese woman with chronic hepatitis B (CHB) diagnosed in 1999 …...","PeriodicalId":19338,"journal":{"name":"North American journal of medicine & science","volume":"10 1","pages":"50"},"PeriodicalIF":0.0,"publicationDate":"2011-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82860957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic Approach to Hepatitis B Virus (HBV) Infection 乙肝病毒(HBV)感染的诊断方法
Pub Date : 2011-01-31 DOI: 10.7156/V4I1P027
H. Te
Hepatitis B infection is a global health problem, leading to cirrhosis and hepatocellular carcinoma in some patients and accounting for 6,000 deaths annually. The diagnosis of HBV infection is based largely on the interpretation of serologic markers and hepatitis B DNA levels, which allows establishment of the phase of infection and provides the groundwork for management strategies. More recently, genotyping and detection of genetic mutations that confer drug resistance provide additional data that assist in the therapeutic decisions. Histologic staging also presents important information that allows for individualized management of the disease. This paper reviews the various tests utilized in the diagnosis of HBV infection and their roles in the identification of the different phases of infection and in the determination of the need for further management.
乙型肝炎感染是一个全球性的健康问题,在一些患者中导致肝硬化和肝细胞癌,每年造成6 000人死亡。HBV感染的诊断主要基于血清学标记物和乙型肝炎DNA水平的解释,这允许建立感染阶段并为管理策略提供基础。最近,基因分型和检测产生耐药性的基因突变提供了辅助治疗决策的额外数据。组织学分期也提供了重要的信息,允许个体化管理的疾病。本文综述了用于诊断HBV感染的各种测试及其在识别感染的不同阶段和确定进一步管理需要中的作用。
{"title":"Diagnostic Approach to Hepatitis B Virus (HBV) Infection","authors":"H. Te","doi":"10.7156/V4I1P027","DOIUrl":"https://doi.org/10.7156/V4I1P027","url":null,"abstract":"Hepatitis B infection is a global health problem, leading to cirrhosis and hepatocellular carcinoma in some patients and accounting for 6,000 deaths annually. The diagnosis of HBV infection is based largely on the interpretation of serologic markers and hepatitis B DNA levels, which allows establishment of the phase of infection and provides the groundwork for management strategies. More recently, genotyping and detection of genetic mutations that confer drug resistance provide additional data that assist in the therapeutic decisions. Histologic staging also presents important information that allows for individualized management of the disease. This paper reviews the various tests utilized in the diagnosis of HBV infection and their roles in the identification of the different phases of infection and in the determination of the need for further management.","PeriodicalId":19338,"journal":{"name":"North American journal of medicine & science","volume":"74 1","pages":"27"},"PeriodicalIF":0.0,"publicationDate":"2011-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72958327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
The role of SIRT1 in tumorigenesis. SIRT1在肿瘤发生中的作用。
Pub Date : 2011-01-01 DOI: 10.7156/v4i2p104
Kai Li, Jianyuan Luo

NAD-dependent Class III histone deacetylase SIRT1 is a multiple functional protein and has been demonstrated critically involved in stress response, cellular metabolism and aging through deacetylating variety of substrates including p53, forkhead transcription factors, PGC-1α, NF-κB, Ku70 and histones. Increasing evidences indicate that SIRT1 plays a complex role in tumorigenesis with functions in both tumor promoting and tumor suppressing. This review provides an overview of current knowledge of SIRT1 and its controversies regarding the functions of SIRT1 in tumorigenesis.

nad依赖性III类组蛋白去乙酰化酶SIRT1是一种多种功能蛋白,已被证明通过使多种底物(包括p53、叉头转录因子、PGC-1α、NF-κB、Ku70和组蛋白)去乙酰化,在应激反应、细胞代谢和衰老中发挥重要作用。越来越多的证据表明,SIRT1在肿瘤发生过程中发挥着复杂的作用,具有促肿瘤和抑肿瘤的双重功能。本文综述了SIRT1的最新知识以及SIRT1在肿瘤发生中的作用。
{"title":"The role of SIRT1 in tumorigenesis.","authors":"Kai Li,&nbsp;Jianyuan Luo","doi":"10.7156/v4i2p104","DOIUrl":"https://doi.org/10.7156/v4i2p104","url":null,"abstract":"<p><p>NAD-dependent Class III histone deacetylase SIRT1 is a multiple functional protein and has been demonstrated critically involved in stress response, cellular metabolism and aging through deacetylating variety of substrates including p53, forkhead transcription factors, PGC-1α, NF-κB, Ku70 and histones. Increasing evidences indicate that SIRT1 plays a complex role in tumorigenesis with functions in both tumor promoting and tumor suppressing. This review provides an overview of current knowledge of SIRT1 and its controversies regarding the functions of SIRT1 in tumorigenesis.</p>","PeriodicalId":19338,"journal":{"name":"North American journal of medicine & science","volume":"4 2","pages":"104-106"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3237400/pdf/nihms-341261.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30334735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 39
Overcoming Barriers to Cervical Cancer Screening Among Asian American Women. 亚裔美国女性克服宫颈癌筛查障碍
Pub Date : 2011-01-01 DOI: 10.7156/v4i2p077
Carolyn Y Fang, Grace X Ma, Yin Tan

Significant disparities in cervical cancer incidence and mortality exist among ethnic minority women, and in particular, among Asian American women. These disparities have been attributed primarily to differences in screening rates across ethnic/racial groups. Asian American women have one of the lowest rates of screening compared to other ethnic/racial groups. Yet Asian Americans, who comprise one of the fastest growing populations in the United States, have received the least attention in cancer control research. Studies suggest that various factors, including lack of knowledge, psychosocial and cultural beliefs, and access barriers, are associated with cervical cancer screening behaviors among Asian American women. Indeed, the few interventions that have been developed for Asian American women demonstrate that targeting these factors can yield significant increases in screening rates. It is important to note, however, that the effectiveness of educational interventions is often attenuated if access barriers are not adequately addressed. Hence, interventions that include key essential components, such as the use of community individuals as lay health workers, culturally-tailored and linguistically-appropriate educational materials, and navigation assistance to overcome access barriers, are more likely to be successful in enhancing screening rates. As the benefits of community-based cervical cancer prevention programs become more apparent, it will be essential to identify effective approaches for disseminating such programs more broadly. In conclusion, community-based cervical cancer screening programs have demonstrated promise in addressing existing cervical cancer disparities by increasing awareness and knowledge and promoting recommended screening behaviors. These findings will be instrumental in guiding future community-based programs to reduce cervical cancer health disparities among Asian American women.

少数族裔妇女,特别是亚裔美国妇女在子宫颈癌发病率和死亡率方面存在显著差异。这些差异主要归因于不同民族/种族群体之间筛查率的差异。与其他族裔/种族相比,亚裔美国女性的筛查率最低。然而,作为美国人口增长最快的群体之一,亚裔美国人在癌症控制研究中受到的关注最少。研究表明,各种因素,包括缺乏知识,社会心理和文化信仰,以及获取障碍,与亚裔美国女性的宫颈癌筛查行为有关。事实上,针对亚裔美国女性的一些干预措施表明,针对这些因素可以显著提高筛查率。然而,必须指出的是,如果不充分解决入学障碍,教育干预措施的效力往往会减弱。因此,包括关键基本组成部分的干预措施,如利用社区个人作为非专业卫生工作者、根据文化量身定制和适合语言的教育材料,以及为克服获取障碍而提供导航协助,更有可能成功提高筛查率。随着以社区为基础的宫颈癌预防项目的好处越来越明显,确定有效的方法来更广泛地传播这些项目将是至关重要的。总之,基于社区的宫颈癌筛查项目通过提高认识和知识以及推广推荐的筛查行为,在解决现有的宫颈癌差异方面表现出了希望。这些发现将有助于指导未来以社区为基础的项目,以减少亚裔美国妇女宫颈癌的健康差异。
{"title":"Overcoming Barriers to Cervical Cancer Screening Among Asian American Women.","authors":"Carolyn Y Fang,&nbsp;Grace X Ma,&nbsp;Yin Tan","doi":"10.7156/v4i2p077","DOIUrl":"https://doi.org/10.7156/v4i2p077","url":null,"abstract":"<p><p>Significant disparities in cervical cancer incidence and mortality exist among ethnic minority women, and in particular, among Asian American women. These disparities have been attributed primarily to differences in screening rates across ethnic/racial groups. Asian American women have one of the lowest rates of screening compared to other ethnic/racial groups. Yet Asian Americans, who comprise one of the fastest growing populations in the United States, have received the least attention in cancer control research. Studies suggest that various factors, including lack of knowledge, psychosocial and cultural beliefs, and access barriers, are associated with cervical cancer screening behaviors among Asian American women. Indeed, the few interventions that have been developed for Asian American women demonstrate that targeting these factors can yield significant increases in screening rates. It is important to note, however, that the effectiveness of educational interventions is often attenuated if access barriers are not adequately addressed. Hence, interventions that include key essential components, such as the use of community individuals as lay health workers, culturally-tailored and linguistically-appropriate educational materials, and navigation assistance to overcome access barriers, are more likely to be successful in enhancing screening rates. As the benefits of community-based cervical cancer prevention programs become more apparent, it will be essential to identify effective approaches for disseminating such programs more broadly. In conclusion, community-based cervical cancer screening programs have demonstrated promise in addressing existing cervical cancer disparities by increasing awareness and knowledge and promoting recommended screening behaviors. These findings will be instrumental in guiding future community-based programs to reduce cervical cancer health disparities among Asian American women.</p>","PeriodicalId":19338,"journal":{"name":"North American journal of medicine & science","volume":"4 2","pages":"77-83"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3115728/pdf/nihms285936.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30250048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 61
Role of Lysosomal Cathepsins in Post-Myocardial Infarction Remodeling 溶酶体组织蛋白酶在心肌梗死后重构中的作用
Pub Date : 2011-01-01 DOI: 10.7156/V4I4P173
Han Chen, Jing Wang, Jian-an Wang, G. Shi
Left ventricular remodeling after myocardial infarction (MI) includes extensive cardiac cell death, inflammatory cell infiltration, cell differentiation, and scar formation. Lysosomal proteases cathepsins participate in all these events during post-MI cardiac repair. These cathepsins cleave Bcl-2 interacting protein Bid, and degrade the anti-apoptotic members Bcl-2, Bcl-xL and Mcl-1, thereby triggering a mitochondrial pathway of apoptosis. Cathepsins also contribute to monocyte and macrophage differentiation and migration. Monocytes, macrophages, and neutrophils are recruited to the site of infarction, where they also release lysosomal cathepsins as inflammatory mediators to regulate post-MI inflammatory responses. Cathepsins also regulate fibroblast trans-differentiation and further affect collagen or other matrix protein synthesis during post-MI extracellular matrix remodeling.
心肌梗死(MI)后左心室重构包括广泛的心肌细胞死亡、炎症细胞浸润、细胞分化和瘢痕形成。溶酶体蛋白酶、组织蛋白酶参与心肌梗死后心脏修复过程中的所有这些事件。这些组织蛋白酶裂解Bcl-2相互作用蛋白Bid,降解抗凋亡成员Bcl-2、Bcl-xL和Mcl-1,从而触发线粒体凋亡途径。组织蛋白酶还有助于单核细胞和巨噬细胞的分化和迁移。单核细胞、巨噬细胞和中性粒细胞被招募到梗死部位,在那里它们也释放溶酶体组织蛋白酶作为炎症介质来调节心肌梗死后的炎症反应。组织蛋白酶还调节成纤维细胞的反式分化,并进一步影响心肌梗死后细胞外基质重塑过程中胶原或其他基质蛋白的合成。
{"title":"Role of Lysosomal Cathepsins in Post-Myocardial Infarction Remodeling","authors":"Han Chen, Jing Wang, Jian-an Wang, G. Shi","doi":"10.7156/V4I4P173","DOIUrl":"https://doi.org/10.7156/V4I4P173","url":null,"abstract":"Left ventricular remodeling after myocardial infarction (MI) includes extensive cardiac cell death, inflammatory cell infiltration, cell differentiation, and scar formation. Lysosomal proteases cathepsins participate in all these events during post-MI cardiac repair. These cathepsins cleave Bcl-2 interacting protein Bid, and degrade the anti-apoptotic members Bcl-2, Bcl-xL and Mcl-1, thereby triggering a mitochondrial pathway of apoptosis. Cathepsins also contribute to monocyte and macrophage differentiation and migration. Monocytes, macrophages, and neutrophils are recruited to the site of infarction, where they also release lysosomal cathepsins as inflammatory mediators to regulate post-MI inflammatory responses. Cathepsins also regulate fibroblast trans-differentiation and further affect collagen or other matrix protein synthesis during post-MI extracellular matrix remodeling.","PeriodicalId":19338,"journal":{"name":"North American journal of medicine & science","volume":"105 1","pages":"173"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77692991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Delayed Hemolytic Transfusion Reaction due to Anti-Jkb: Case Report Highlighting the Importance of Early Blood Bank Consultation and Literature Review 抗jkb引起的延迟溶血性输血反应:强调早期血库咨询重要性的病例报告及文献复习
Pub Date : 2010-10-31 DOI: 10.7156/V3I4P187
D. M. Nguyen, H. J. Lee, D. Mirabella, D. W. Wu
Delayed hemolytic transfusion reactions (DHTR) can be asymptomatic or mimic other conditions and may be misdiagnosed. Failure to recognize this entity could lead to inappropriate treatment and future transfusions reactions. Anti-JK a and anti-JK b are the most frequently encountered antibodies responsible for DHTR ac companied by intravascular hemolysis on rare occasions. The antibodies are often difficult to detect because of their transient nature and their frequent dosage effect. We report the case of a 40-year-old female with DHTR due to unexpected weakly reactive anti-JK b . The patient, with a medical history of hypertension, multiple transfusions, multiple abortions and vaginal bleeding due to uterine fibroids, presented to our emergency department complaining of back pain for four days and red-brown color urine for one day. Significant jaundice was noted on physical examination. Laboratory data showed low hemoglobin (Hb) (6.0g/dl) and increased creatinine (3.11 mg/dl). Differential diagnosis included hemolytic-uremic syndrome, hematuria caused by urinary tract calculi, and autoimmne hemolytic anemia. Significant hemolysis was observed in the patient’s blood sample.    Further   questioning   elicited   a   recent  blood  transfusion seven days prior. Red cell antibody work-up at that time showed the presence of anti-K and anti-E. The patient was transfused 2 units of K and E antigen negative cross-match compatible packed red blood cells(PRBCs). Post-transfusion Hb was 8.8 g/dl and there were no signs of any immediate complication. Review of the recent history of blood transfusion and the current findings led to our strong suspicion of intravascular hemolysis. The patient was treated vigorously with fluids and intravenous diuretics. Stat tests subsequently confirmed the intravascular hemolysis. A ‘new’ request for blood transfusion was put on hold while an antibody workup was initiated. Red cell antibody work-up results confirmed the presence of anti-K and anti-E; the direct antiglobulin test (DAT) was negative. An eluate prepared from the patient’s red cells was non-reactive by indirect antiglobulin test. Additional samples were sent to a reference laboratory for further investigation of unexpected red cell antibodies. Results from the reference laboratory confirmed the anti-E and -K, and, in addition, a weak anti- JK b was identified in the plasma and eluate. Both of the prior transfused units were subsequently shown to be Jk(b+), adding further evidence that the anti- JK b is most likely the culprit of the DHTR. The patient was subsequently transfused with E-, K- and Jk(b-) PRBCs and her condition improved. This case emphasizes the central role of blood bank consultation for early treatment and diagnosis of DHTR and for the avoidance of incompatible blood component transfusion, thus minimizing the risks of morbidity and reduce the potential for mortality. It is our opinion that blood bankers should be consulted when patients have an acu
迟发性溶血性输血反应(DHTR)可无症状或模仿其他情况,并可能被误诊。未能认识到这一实体可能导致不适当的治疗和未来的输血反应。Anti-JK a和Anti-JK b是引起DHTR ac的最常见抗体,在极少数情况下伴有血管内溶血。由于抗体的短暂性和频繁的剂量效应,通常很难检测到抗体。我们报告一例40岁女性因意外的弱反应性抗jk b而患有DHTR。患者既往有高血压、多次输血、多次流产、子宫肌瘤所致阴道出血等病史,以腰痛4天、尿红棕色1天就诊于急诊科。体格检查发现明显黄疸。实验室数据显示血红蛋白(Hb)低(6.0g/dl),肌酐升高(3.11 mg/dl)。鉴别诊断包括溶血性尿毒症综合征、尿路结石引起的血尿和自身免疫性溶血性贫血。患者血样中观察到明显的溶血现象。进一步的询问引出了7天前的一次输血。当时的红细胞抗体检查显示存在抗k和抗e。患者输注2单位K、E抗原阴性交叉配型相容填充红细胞(PRBCs)。输血后Hb为8.8 g/dl,没有任何立即并发症的迹象。回顾最近的输血史和目前的发现,我们强烈怀疑是血管内溶血。病人接受了输液和静脉利尿剂的大力治疗。随后的Stat检查证实了血管内溶血。在启动抗体检查时,一个“新的”输血请求被搁置。红细胞抗体检查结果证实存在抗k和抗e;直接抗球蛋白试验(DAT)阴性。间接抗球蛋白试验表明,从患者红细胞制备的洗脱液无反应性。额外的样本被送到参比实验室进一步调查意外的红细胞抗体。参考实验室的结果证实了抗e和- k,此外,在血浆和洗脱液中发现了弱抗JK b。两种先前输入的单位随后被证明是Jk(b+),进一步证明抗Jk b很可能是DHTR的罪魁祸首。患者随后输注E-、K-和Jk(b-)红细胞,病情得到改善。该病例强调了血库咨询对DHTR的早期治疗和诊断以及避免不相容血液成分输血的核心作用,从而最大限度地减少发病率风险并降低死亡率的可能性。我们的意见是,当患者在最近输血后Hb急剧下降时,应咨询血库。输血医学应成为医学院教育和医院大会诊的一部分,提高临床医生对DHTR的认识和报告,及时诊断和治疗。
{"title":"Delayed Hemolytic Transfusion Reaction due to Anti-Jkb: Case Report Highlighting the Importance of Early Blood Bank Consultation and Literature Review","authors":"D. M. Nguyen, H. J. Lee, D. Mirabella, D. W. Wu","doi":"10.7156/V3I4P187","DOIUrl":"https://doi.org/10.7156/V3I4P187","url":null,"abstract":"Delayed hemolytic transfusion reactions (DHTR) can be asymptomatic or mimic other conditions and may be misdiagnosed. Failure to recognize this entity could lead to inappropriate treatment and future transfusions reactions. Anti-JK a and anti-JK b are the most frequently encountered antibodies responsible for DHTR ac companied by intravascular hemolysis on rare occasions. The antibodies are often difficult to detect because of their transient nature and their frequent dosage effect. We report the case of a 40-year-old female with DHTR due to unexpected weakly reactive anti-JK b . The patient, with a medical history of hypertension, multiple transfusions, multiple abortions and vaginal bleeding due to uterine fibroids, presented to our emergency department complaining of back pain for four days and red-brown color urine for one day. Significant jaundice was noted on physical examination. Laboratory data showed low hemoglobin (Hb) (6.0g/dl) and increased creatinine (3.11 mg/dl). Differential diagnosis included hemolytic-uremic syndrome, hematuria caused by urinary tract calculi, and autoimmne hemolytic anemia. Significant hemolysis was observed in the patient’s blood sample.    Further   questioning   elicited   a   recent  blood  transfusion seven days prior. Red cell antibody work-up at that time showed the presence of anti-K and anti-E. The patient was transfused 2 units of K and E antigen negative cross-match compatible packed red blood cells(PRBCs). Post-transfusion Hb was 8.8 g/dl and there were no signs of any immediate complication. Review of the recent history of blood transfusion and the current findings led to our strong suspicion of intravascular hemolysis. The patient was treated vigorously with fluids and intravenous diuretics. Stat tests subsequently confirmed the intravascular hemolysis. A ‘new’ request for blood transfusion was put on hold while an antibody workup was initiated. Red cell antibody work-up results confirmed the presence of anti-K and anti-E; the direct antiglobulin test (DAT) was negative. An eluate prepared from the patient’s red cells was non-reactive by indirect antiglobulin test. Additional samples were sent to a reference laboratory for further investigation of unexpected red cell antibodies. Results from the reference laboratory confirmed the anti-E and -K, and, in addition, a weak anti- JK b was identified in the plasma and eluate. Both of the prior transfused units were subsequently shown to be Jk(b+), adding further evidence that the anti- JK b is most likely the culprit of the DHTR. The patient was subsequently transfused with E-, K- and Jk(b-) PRBCs and her condition improved. This case emphasizes the central role of blood bank consultation for early treatment and diagnosis of DHTR and for the avoidance of incompatible blood component transfusion, thus minimizing the risks of morbidity and reduce the potential for mortality. It is our opinion that blood bankers should be consulted when patients have an acu","PeriodicalId":19338,"journal":{"name":"North American journal of medicine & science","volume":"20 1","pages":"187"},"PeriodicalIF":0.0,"publicationDate":"2010-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89027180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
North American journal of medicine & science
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1